Who owns Apellis Pharmaceuticals Inc?
- CUSIP Number: 03753u106
Tip: Access positions for across all investors
Analyze quarterly positions in Apellis Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Apellis Pharmaceuticals stock
Who bought or sold Apellis Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Morgan Stanley | 10M | $404M | 9% | Mar 2026 |
|
| State Street Corporation | 6.8M | $275M | 48% | Mar 2026 |
|
| Citigroup | 717k | $29M | 100% | Mar 2026 |
|
| Henderson Group | 252k | $10M | 100% | Mar 2026 |
|
| Bank Of Montreal | 215k | $8.7M | 100% | Mar 2026 |
|
| T. Rowe Price Associates | 107k | $4.3M | 12% | Mar 2026 |
|
| CIBRA Capital | 50k | $2.0M | 100% | Mar 2026 |
|
| CWM | 11k | $459k | -73% | Mar 2026 |
|
| Bck Capital Management | 8.0k | $322k | 100% | Mar 2026 |
|
| Mirae Asset Global Investments | 6.7k | $268k | 8% | Mar 2026 |
|
| IFP Advisors | 248.00 | $10k | -47% | Jun 2026 |
|
| Evelyn Partners Investment Management | 150.00 | $6.0k | 0% | Mar 2026 |
|
| Parkside Financial Bank & Trust | 119.00 | $4.8k | 261% | Mar 2026 |
|
| Financial Gravity Wealth | 100.00 | $4.0k | 0% | Mar 2026 |
|